A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
This is an exploratory study in a small, well controlled group of healthy subjects to explore
the effect of CXA-10 on pravastatin and Vytorin® (combination of simvastatin and ezetimibe).
Phase:
Phase 1
Details
Lead Sponsor:
Complexa, Inc.
Treatments:
CXA-10 Ezetimibe Ezetimibe, Simvastatin Drug Combination Pravastatin Simvastatin